Rutarin
Rutarin is a Coumarin derivative with antimalarial and antifungal activities. Rutarin inhibits Plasmodium falciparum with an IC50 of 88 μg/mL. Rutarin also inhibits Coniophora cerebella[1][2][3].
Product Specifications
CAS Number
20320-81-4
UNSPSC
12352005
Target
Drug Derivative; Fungal; Parasite
Type
Natural Products
Related Pathways
Anti-infection; Others
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/rutarin.html
Purity
99.84
Solubility
10 mM in DMSO
Smiles
O=C1C=CC2=CC3=C(C(OC4C(O)C(O)C(O)C(O4)CO)=C2O1)OC(C3)C(O)(C)C
Molecular Formula
C20H24O10
Molecular Weight
424.40
References & Citations
[1]Banerji A, et al. Prenylated compounds from Atalantia racemosa: isolation and synthesis of two pyranoflavones. Phytochemistry, 1988, 27 (11) :3637-3640.|[2]Lacroix D, et al. Structure and in vitro antiparasitic activity of constituents of Citropsis articulata root bark. J Nat Prod. 2011 Oct 28;74 (10) :2286-9. |[3]Wolters B, et al. Antimicrobial substances in callus cultures of Ruta graveolens. Planta Med. 1981 Oct;43 (2) :166-74.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Natural Products
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6135733-01 0.1 mL
CD178 (Apoptosis Antigen Ligand, APT1LG1, APTL, CD95 Ligand, CD95L, CD95-L, FAS Antigen Ligand, Fas Ligand, FASL, FASLG, Tumor Necrosis Factor Ligand Superfamily Member 6, TNFSF6) APC
Sign In for Pricing
View Details MBS6135733-02 5x 0.1 mL
CD178 (Apoptosis Antigen Ligand, APT1LG1, APTL, CD95 Ligand, CD95L, CD95-L, FAS Antigen Ligand, Fas Ligand, FASL, FASLG, Tumor Necrosis Factor Ligand Superfamily Member 6, TNFSF6) APC
Sign In for Pricing
View Details 
NMD3-6107M 50 µg
Recombinant Mouse NMD3 Protein, His (Fc)-Avi-tagged
Sign In for Pricing
View Details 
bs-5247R-FITC 100 µL
Phospho-CDK1 (Ser39) Polyclonal Antibody, FITC Conjugated
Sign In for Pricing
View Details